Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patientsFrederik A Verburg, Michael Lassmann, Uwe Mäder, et al.
Clinical Endocrinology|December 15, 2018
The time point of completion thyroidectomy has no prognostic impact in patients with differentiated thyroid cancerChristina Lenschow, Uwe Mäder, Christoph-Thomas Germer, et al.
Clinical Endocrinology|October 30, 2009
A comparison of prognostic classification systems for differentiated thyroid carcinomaFrederik A Verburg, Uwe Mäder, Cas L J J Kruitwagen, et al.
Thyroid : Official Journal of the American Thyroid Association|April 8, 2004
Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995Jamshid Farahati, Markus Geling, Uwe Mäder, et al.
Nuklearmedizin. Nuclear Medicine|March 28, 2019
Changing trends of incidence and prognosis of thyroid carcinomaJamshid Farahati, Uwe Mäder, Elena Gilman, et al.
Clinical Endocrinology|November 9, 2011
Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinomaStefanie Diessl, Barbara Holzberger, Uwe Mäder, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2009
Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adultsPatricia Doyle, Christian Düren, Kai Nerlich, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2009
Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective studyMarkus Luster, Daria Handkiewicz-Junak, Armando Grossi, et al.
Plos One|October 8, 2013
CIP2A influences survival in colon cancer and is critical for maintaining Myc expressionArmin Wiegering, Christina Pfann, Friedrich Wilhelm Uthe, et al.
Pageof 3